Trade Summary

3 days ago, Mensinger Mike, serving as Chief Product Officer at Beta Bionics, Inc. (BBNX), sold 4,378 shares at $12.61 per share, for a total transaction value of $55,193.88. Following this transaction, Mensinger Mike now holds 184,415 shares of BBNX.

This sale represents a 2.32% decrease in Mensinger Mike's stake in the company. This is considered a medium-conviction trade.

The trade was executed on Tuesday, June 2, 2026 and publicly disclosed via SEC Form 4 filing on Wednesday, June 3, 2026 at 6:13 PM ET, 1 day after the trade was made.

Beta Bionics, Inc. operates in the HEALTHCARE sector, specifically within the MEDICAL DEVICES industry. Insider selling activity in this sector can provide valuable signals about industry trends and company-specific developments.